Trial Profile
The effects of Belsomra on sleep of REM sleep behavior disorder measured by portable polysomnography
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2016
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications REM-sleep-behavior-disorder
- Focus Therapeutic Use
- 26 May 2016 New trial record